Related Experiment Video
Updated: Apr 15, 2026
Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Novel insights into no-reflow post-PCI: The predictive value of coronary sinus hemodynamics
Shimaa Gamal Zein-Elabdeen1, Mahmoud Abdelaziz Abdelrashid1, Montaser Elsekely1
1Cardiology Department, Zagazig University, Faculty of Medicine, Sharkya, Egypt.
Insights
Prolonged coronary sinus filling time (CSFT) is a predictor of no-reflow (NR) after percutaneous coronary intervention (PCI). Measuring CSFT can help identify patients at risk for NR, improving outcomes in acute myocardial infarction.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Research
Background:
- Coronary no-reflow (NR) is a serious complication of percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI), leading to increased mortality.
- Identifying novel predictors for NR is crucial for timely management and improved patient outcomes.
Purpose of the Study:
- To measure coronary sinus filling time (CSFT) in patients undergoing primary PCI.
- To evaluate the potential of CSFT as a predictor for the no-reflow phenomenon during primary PCI.
Main Methods:
- 180 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI were studied.
- Patients were divided into no-reflow (n=69) and normal reflow (n=111) groups.
- Coronary sinus filling time (CSFT) was measured post-revascularization.
Main Results:
- No-reflow occurred in 38.3% of patients.
- CSFT was significantly longer in the NR group (69.13 ± 12.20 frames) versus the normal reflow group (60.19 ± 23.22 frames), p=0.001.
- Independent predictors of NR included diabetes, hypertension, smoking, non-compliant balloon use, and CSFT. An optimal CSFT cutoff of >66 frames predicted NR with 60.9% sensitivity and 78.4% specificity.
Conclusions:
- Coronary sinus filling time (CSFT) is a valuable, underutilized tool for predicting and identifying no-reflow during PCI.
- Prolonged CSFT indicates impaired microvascular perfusion and may serve as an early physiological marker for impending no-reflow.
- This finding supports the use of CSFT in clinical practice for risk stratification in AMI patients undergoing PCI.
Background:
Coronary no-reflow (NR) represents a significant complication associated with increased mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention (PCI). The identification of novel predictors for early recognition and timely management warrants investigation in order to improve patient outcomes.
Aim:
The coronary sinus has emerged as a versatile tool in various diagnostic and therapeutic interventions. Accordingly, we aimed to measure coronary sinus filling time (CSFT) in patients who developed NR during primary PCI and evaluate its potential role in NR prediction.
Methods:
A total of 180 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI were enrolled in this study. Patients were stratified into two groups based on the occurrence of no-reflow phenomenon: the NR group (n = 69) and the normal reflow group (n = 111). CSFT was measured following culprit vessel revascularization.
Results:
NR developed in 38.3% of patients. CSFT was significantly prolonged in the NR group compared with the normal reflow group (69.13 ± 12.20 vs. 60.19 ± 23.22 frame counts, p = 0.001). Regression analysis identified five independent predictors of NR: diabetes mellitus, hypertension, smoking, use of non-compliant balloon, and CSFT. The optimal CSFT cut-off value for predicting NR was >66 frame counts, with a sensitivity of 60.9% and specificity of 78.4%. The area under the receiver operating characteristic curve was 0.722 (p = 0.004).
Conclusion:
Coronary sinus filling time represents an underutilized yet potentially valuable tool for the prediction and early identification of the no-reflow phenomenon during PCI. Our findings suggest that prolonged CSFT correlates with impaired microvascular perfusion and may serve as an early physiological indicator of impending no-reflow.
